维普中文期刊产品整合服务
158篇 您的检索式:作者名="MILELLA M"
    题名 作者 年代 出处 被引量
1Gemcitabine-based combinations for inoperable pancreatic cancer:have we made real progress?A meta-analysis of 20 phase 3 trials显示文摘Bria E Milella M Gelibter A 2007Cancer2007,110,3:1
2Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors:an important role for mutations in minor clones显示文摘Marchetti A Milella M Felicioni L 0,,:1
3FOLFIRINOX versus gem- citabine for metastatic pancreatic cancer 显示文摘Vaccaro V Sperduti I Milella M 2011N Engl J Med2011,365,8:1
4Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia显示文摘Milella M Estrov Z Kornblau SM 2002Blood2002,99,9:1
5First Line gefitinib (G) for advanced non small cell lung cancer (NSCLC) patients (pts) har- bouring sensitizing epidermal growth factor receptor mutations (EGFR M) Meta-analysis of randomized trials (RCT) explo- ring the magnitude of benefits over chemotherapy (CT) 显示文摘Ciannarelli D Bria E Milella M 2010J Clin Oncol2010,,:1
6Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research 显示文摘Bonomi M Pilotto S Milella M 2011J Exp Clin Cancer Res2011,30,1:1
7FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer显示文摘Vaccaro V Sperduti I Milella M 2011N Engl J Med2011,365,8:1
8Cytotkine-regulated expression of survivln in myeloid leukemia显示文摘Carter BZ Milella M Ahieri DC et a1 2001Blood2001,97,9:1
9Anti-Hbe-Positive Chronic hepatits B with HBVDNA in the serum response to a 6 month course of lymphoblastiold interforon 显示文摘Pastore G Santantonio T Milella M 1992J Hepatol1992,14,:1
10Be-yond single path-way inhibition:MEK inhibitors as a platform for the development ofpharmacological combinations with synergistic anti-leukemiceffects显示文摘Milella M Precupanu CM Gregorj C 2005Curr Pharm Des2005,11,:1
11Cytokine-regulated expression of survivin in myeloid leukemia显示文摘Carter BZ Milella M Altieri DC 0,,:1
12Trastuzumab cardio toxicity:biological hypotheses and clinical open issues显示文摘Bria E Cuppone F Milella M 2015Expert Opin Biol Ther2015,8,12:1
13Cytokine-regulated expression of survivin in myeloid leukemia 显示文摘Carter BZ Milella M Altieri DC 2001Blood2001,97,9:1
14Neutralizig antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection显示文摘Milella M Antonelli G Santantono T 1993Liver1993,13,3:1
15EGFR molecular profiling in advanced NSCLC:a prospective phase Ⅱ study in molecularly/clinicallyselected patients pretreated with chemotherapy显示文摘Milella M Nuzzo C Bria E 0,,04:1
16Cytokine regulated expression of survivin in myeloid leukemia 显示文摘Carter B Z Milella M Alteiri DC 2001Blood2001,97,9:1
17The mitogen-activated protein kinase signaling module as a therapeutic target in hematologic malignancies显示文摘Milella M Kornblau SM Andreeff M 2003Rev Clin Exp Hematol2003,7,2:1
18Neutralizing antibodies to recombinant alpha interferon and response to therapy in chronic hapatitis C rirus infection 显示文摘Milella M Antonelli G Santantonio T 1993Liver1993,13,:1
19Cytokine-regulated expression of survivin in myeloid leukemia 显示文摘 Milella M Altieri DC 2001Blood2001,97,9:1
20Cytokine-regulated expression of survivin in myeloid leukemia 显示文摘Carter BZ Milella M Altieri DC 2001Blood2001,97,:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费